Brief: ALX Oncology Q3 Basic EPS USD -1.24
13/11/2023 21:05
Nov 13 (Reuters) - ALX Oncology Q3 operating expenses USD 53.275 million. * Q3 net income USD -50.99 million * Q3 income from operations USD -53.275 million
Recent news on ALX Oncology Holdings
See all newsALX Oncology Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
ALX Oncology Holdings Inc expected to post a loss of 15 cents a share - Earnings Preview
ALX Oncology Q2 net loss narrows on lower R&D costs
Brief: ALX Oncology Q2 Basic EPS USD -0.13
Brief: Alx Oncology Holdings - Enters Loan And Security Agreement With HSBC Ventures On June 25, 2026 - SEC Filing